Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.
Vasen HFA, Boekestijn B, Ibrahim IS, Inderson A, Bonsing BA, de Vos Tot Nederveen Cappel WH, Feshtali S, Wasser MN. Vasen HFA, et al. Among authors: feshtali s. HPB (Oxford). 2019 Oct;21(10):1371-1375. doi: 10.1016/j.hpb.2019.02.013. Epub 2019 Mar 22. HPB (Oxford). 2019. PMID: 30910317 Free article.
Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer.
Sibinga Mulder BG, Mieog JS, Handgraaf HJ, Farina Sarasqueta A, Vasen HF, Potjer TP, Swijnenburg RJ, Luelmo SA, Feshtali S, Inderson A, Vahrmeijer AL, Bonsing BA, van Wezel T, Morreau H. Sibinga Mulder BG, et al. Among authors: feshtali s. J Clin Pathol. 2017 Feb;70(2):174-178. doi: 10.1136/jclinpath-2016-203928. Epub 2016 Sep 26. J Clin Pathol. 2017. PMID: 27672215
Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer.
Sibinga Mulder BG, Mieog JSD, Farina Sarasqueta A, Handgraaf HJ, Vasen HFA, Swijnenburg RJ, Luelmo SAC, Feshtali S, Inderson A, Vahrmeijer AL, Bonsing BA, Wezel TV, Morreau H. Sibinga Mulder BG, et al. Among authors: feshtali s. J Clin Pathol. 2018 Mar;71(3):246-252. doi: 10.1136/jclinpath-2017-204607. Epub 2017 Aug 3. J Clin Pathol. 2018. PMID: 28775172
Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers.
Ibrahim I, Sibinga Mulder BG, Bonsing B, Morreau H, Farina Sarasqueta A, Inderson A, Luelmo S, Feshtali S, Potjer TP, de Vos Tot Nederveen Cappel W, Wasser M, Vasen HFA. Ibrahim I, et al. Among authors: feshtali s. Eur J Hum Genet. 2018 Aug;26(8):1227-1229. doi: 10.1038/s41431-018-0170-y. Epub 2018 May 16. Eur J Hum Genet. 2018. PMID: 29769629 Free PMC article.
High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.
Ibrahim IS, Wasser MN, Wu Y, Inderson A, de Vos Tot Nederveen Cappel WH, Morreau H, Hes FJ, Veenendaal RA, Putter H, Feshtali S, van Mil AM, Gruis NA, Tollenaar RA, Bergman W, Bonsing BA, Vasen HFA. Ibrahim IS, et al. Among authors: feshtali s. Cancer Prev Res (Phila). 2018 Sep;11(9):551-556. doi: 10.1158/1940-6207.CAPR-18-0035. Epub 2018 Jul 10. Cancer Prev Res (Phila). 2018. PMID: 29991580
A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer.
Sibinga Mulder BG, Feshtali S, Fariña Sarasqueta A, Vahrmeijer AL, Swijnenburg RJ, Bonsing BA, Mieog JSD. Sibinga Mulder BG, et al. Among authors: feshtali s. Ultrasound Med Biol. 2019 Aug;45(8):2019-2026. doi: 10.1016/j.ultrasmedbio.2019.04.020. Epub 2019 May 24. Ultrasound Med Biol. 2019. PMID: 31130412
Cost-effectiveness of pancreas surveillance: The CDKN2A-p16-Leiden cohort.
Ibrahim IS, Vasen HFA, Wasser MNJM, Feshtali S, Bonsing BA, Morreau H, Inderson A, de Vos Tot Nederveen Cappel WH, van den Hout WB. Ibrahim IS, et al. Among authors: feshtali s. United European Gastroenterol J. 2023 Mar;11(2):163-170. doi: 10.1002/ueg2.12360. Epub 2023 Feb 13. United European Gastroenterol J. 2023. PMID: 36785917 Free PMC article.
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
Klatte DCF, Boekestijn B, Onnekink AM, Dekker FW, van der Geest LG, Wasser MNJM, Feshtali S, Mieog JSD, Luelmo SAC, Morreau H, Potjer TP, Inderson A, Boonstra JJ, Vasen HFA, van Hooft JE, Bonsing BA, van Leerdam ME; Dutch Pancreatic Cancer Group. Klatte DCF, et al. Among authors: feshtali s. Gastroenterology. 2023 Jun;164(7):1223-1231.e4. doi: 10.1053/j.gastro.2023.02.032. Epub 2023 Mar 6. Gastroenterology. 2023. PMID: 36889551 Free article.
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial.
van Dam JL, Verkolf EMM, Dekker EN, Bonsing BA, Bratlie SO, Brosens LAA, Busch OR, van Driel LMJW, van Eijck CHJ, Feshtali S, Ghorbani P, de Groot DJA, de Groot JWB, Haberkorn BCM, de Hingh IH, van der Holt B, Karsten TM, van der Kolk MB, Labori KJ, Liem MSL, Loosveld OJL, Molenaar IQ, Polée MB, van Santvoort HC, de Vos-Geelen J, Wumkes ML, van Tienhoven G, Homs MYV, Besselink MG, Wilmink JW, Groot Koerkamp B; Dutch Pancreatic Cancer Group. van Dam JL, et al. Among authors: feshtali s. BMC Cancer. 2023 Aug 7;23(1):728. doi: 10.1186/s12885-023-11141-5. BMC Cancer. 2023. PMID: 37550634 Free PMC article.
31 results